CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleLevered free cash flow is $34.5M, above the global median of $16.24M
- FinancialsAltman Z-Score 3.53: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
3.03%Above 5Y avg (2.62%)
Annual Rate
CNY 0.30Paid semi-annual
Payout Ratio
50.0%Sustainable
Payback Period
33.1 yr
Last Ex-Dividend
May 29, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.58BCNY681.04M · vs all stocks (USD)
Trailing P/E
15.06xRevenue (TTM)
1.79BCNY266.36M · vs all stocks (USD)
Profit Margin
17.11%Beta
0.2570xvs all stocks
52-Week Change
-18.50%vs all stocks
Forward Annual Dividend Yield
3.03%vs all stocks
Market Capitalization
4.58BCNY681.04M · vs all stocks (USD)
Enterprise Value
4.70BCNY699.63M · vs all stocks (USD)
Trailing P/E
15.06xForward P/E
15.06xPrice to Sales (TTM)
2.58xPrice to Book (MRQ)
2.67xEnterprise to Revenue
2.63xEnterprise to EBITDA
11.80xGross Margin
75.33%Profit Margin
17.11%Operating Margin
22.70%Return on Assets (TTM)
6.48%Return on Equity (TTM)
16.79%Revenue (TTM)
1.79BCNY266.36M · vs all stocks (USD)
Revenue per Share (TTM)
4.09CNYUpdated Aug 21, 2026Quarterly Revenue Growth
10.70%Gross Profit (TTM)
1.30BCNY193.87M · vs all stocks (USD)
EBITDA (TTM)
345.77MCNY51.42M · vs all stocks (USD)
Net Income (TTM)
306.52MCNY45.58M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
0.20%Operating Cash Flow (TTM)
442.89MCNY65.86M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
231.99MCNY34.50M · vs all stocks (USD)
Forward Annual Dividend Rate
0.3000CNYUpdated Aug 21, 2026Forward Annual Dividend Yield
3.03%vs all stocks
Trailing Annual Dividend Rate
0.3000CNYUpdated Aug 21, 2026Trailing Annual Dividend Yield
3.03%vs all stocks
5-Year Average Dividend Yield
2.62%vs all stocks
Payout Ratio
50.00%Minority Interest (Equity)
91.15MCNYFY2025 · Dec 31, 2025Revenue
1.75BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
489.54MCNYFY2025 · Dec 31, 2025Gross Profit
1.26BCNYFY2025 · Dec 31, 2025Operating Income
325.70MCNY48.44M · vs all stocks (USD)
Pre-tax Income
353.24MCNYFY2025 · Dec 31, 2025Income Tax Expense
50.61MCNYFY2025 · Dec 31, 2025Net Income
302.64MCNYFY2025 · Dec 31, 2025EBIT
368.05MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
406.70MCNYFY2025 · Dec 31, 2025Research & Development
154.47MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
541.43MCNYFY2025 · Dec 31, 2025Other Operating Expenses
36.61MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
3.98MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
14.80MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.7000CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.7000CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
437.70MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
437.70MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
302.64MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
3.75MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
289.06MCNYFY2025 · Dec 31, 2025Free Cash Flow
189.16MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
268.17MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
302.64MCNYFY2025 · Dec 31, 2025Other Non-cash Items
19.43MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-62.71MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
29.70MCNYFY2025 · Dec 31, 2025Capital Expenditures
-99.90MCNYFY2025 · Dec 31, 2025Net Acquisitions
24.40MCNYFY2025 · Dec 31, 2025Purchase of Investments
-715.00MCNYFY2025 · Dec 31, 2025Sale of Investments
795.43MCNYFY2025 · Dec 31, 2025Other Investing Activity
76.79MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
81.72MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
363.40MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-638.55MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-193.27MCNYFY2025 · Dec 31, 2025Other Financing Charges
-18.68MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-487.10MCNYFY2025 · Dec 31, 2025Shares Outstanding
439.08MSharesUpdated Aug 21, 2026Float Shares
270.90MSharesUpdated Aug 21, 2026% Held by Insiders
38.63%vs all stocks
% Held by Institutions
10.19%vs all stocks
Total Cash (MRQ)
254.24MCNY37.81M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.5790CNYUpdated Aug 21, 2026Total Debt (MRQ)
405.24MCNY60.26M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.2208xCurrent Ratio (MRQ)
0.9050xBook Value per Share (MRQ)
3.95CNYUpdated Aug 21, 2026Total Assets
3.06BCNY454.42M · vs all stocks (USD)
Total Current Assets
1.01BCNYFY2025 · Dec 31, 2025Total Liabilities
1.25BCNYFY2025 · Dec 31, 2025Total Non-current Assets
2.04BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
102.50MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.15BCNYFY2025 · Dec 31, 2025Cash
268.21MCNYFY2025 · Dec 31, 2025Cash Equivalents
8.05MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
276.25MCNYFY2025 · Dec 31, 2025Accounts Receivable
249.03MCNYFY2025 · Dec 31, 2025Inventory
338.71MCNYFY2025 · Dec 31, 2025Accounts Payable
170.62MCNYFY2025 · Dec 31, 2025Short-term Debt
409.32MCNYFY2025 · Dec 31, 2025Other Current Liabilities
8.17MCNYFY2025 · Dec 31, 2025Long-term Debt
22.72MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
3.62MCNYFY2025 · Dec 31, 2025Common Stock (Book)
439.08MCNYFY2025 · Dec 31, 2025Retained Earnings
922.66MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.80BCNY268.10M · vs all stocks (USD)
52-Week Low
8.64CNYUpdated Aug 21, 202652-Week High
13.50CNYUpdated Aug 21, 202652-Week Change
-18.50%vs all stocks
Beta
0.2570xvs all stocks
50-Day MA
9.59CNYUpdated Aug 21, 2026200-Day MA
10.94CNYUpdated Aug 21, 2026Avg 10-Day Volume
22.12MSharesUpdated Aug 21, 2026Avg 30-Day Volume
14.51MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
0.7000CNYUpdated Aug 21, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.53: safe zoneNotable
Altman Z-Score: 3.53
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Levered free cash flow is $34.5M, above the global median of $16.24MNotable
Levered free cash flow (USD): 34,499,187.692Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Xiangxue Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai ShenQi Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Qianjiang Yongan Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Supriya Lifescience Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
BridgeBio Oncology Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Nanjing Vishee Medical Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Gyre Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Beijing Science Sun Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Henan Taloph Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Knight Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule